Medicare Is Likely to Pay for Anticancer Drugs

BMJ
doi 10.1136/bmj.324.7346.1118/b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Care Patterns in Medicare and Their Implications for Pay for Performance

New England Journal of Medicine
Medicine
2007English

Medicare Part D Payments for Neurologist-Prescribed Drugs

Neurology
Neurology
2016English

Is Radioiodine More Likely Than Antithyroid Drugs to Worsen Ophthalmopathy in Patients With Graves Disease?

Nature Clinical Practice Endocrinology & Metabolism
2008English

Metabolic Monosaccharides Altered Cell Responses to Anticancer Drugs

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2012English

Pricing in the Market for Anticancer Drugs

2015English

Structural Basis for Smoothened Receptor Modulation and Chemoresistance to Anticancer Drugs

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Dendrimers for Drug Delivery of Anticancer Drugs

2015English

KLHL5 Knockdown Increases Cellular Sensitivity to Anticancer Drugs

Oncotarget
Oncology
2018English

Pay-For-Performance or Compliance? A Second Opinion on Medicare Reimbursement

Indiana Health Law Review
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy